Over 12 million Americans are eligible for both Medicare and Medicaid, including roughly 7.5 million adults aged 65 and over and roughly 4.5 million people with disabilities under age 65.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Long-standing Interpretation
[Webinar] No Surprises Act Update: The Latest Litigation, Enforcement and Implementation Challenges - February 16th, 3:00 pm - 4:00 pm ET | JD Supra
The No Surprises Act (NSA), which went into effect January 1, 2022, was designed to protect patients from surprise medical bills when they are treated in out-of-network emergency departments or by out-of-network providers at in-network facilities. It represents a massive change in health patient financial practices—and controversy continues to surround its implementation, particularly around the new federal independent dispute resolution (IDR) process created under the NSA.
CMS Approves First-in-Nation Justice-Involved Reentry Section 1115 Demonstration | JD Supra
The Big Picture On January 26, 2023, the Centers for Medicare & Medicaid Services (CMS) approved California’s request to amend the California Advancing and Innovating Medi-Cal (CalAIM) Section 1115 demonstration. A centerpiece of the amendment is approval for California Medicaid to provide a targeted set of Medicaid services to youth and adults in state prisons, county jails, and youth correctional facilities for up to 90 days prior to release.
Governor Hochul Announces Date for Release of 2023–24 Executive Budget | JD Supra
Governor Kathy Hochul is scheduled to present her 2023–24 Executive budget proposal at noon on Wednesday, February 1, 2023, with the budget bills expected to be released thereafter. This will be Governor Hochul’s first Executive budget proposal since being elected Governor for a full four-year term, although it follows her first budget last year after she ascended to the governorship in September 2021.
FDA Stands By Long-standing Interpretation of the Orphan Drug Act…For Now | JD Supra
On January 24, the Food and Drug Administration (FDA) made a long-awaited announcement with major implications for how the agency awards exclusivity for rare disease drugs under the Orphan Drug Act (ODA) (P.L. 97-414). Specifically, FDA issued a Federal Register notice describing how the agency will respond to an 11th Circuit ruling in Catalyst Pharmaceuticals, Inc. v. Becerra.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Long-standing
Contact Long-standing, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack